title: [Coronary stents and anaesthesia].
abstract: The coronary stents are widely used to prevent coronary restenosis after percutaneous coronary intervention. Dual antiplatelet therapy (acetyl salicylic acid and a thienopyridine-clopidogrel or ticlopidine) are prescribed at least during six weeks after conventional stent and six months after drug eluting stent insertion to prevent stent thrombosis. When an invasive procedure is required, a risk of stent thrombosis arises after stopping antiplatelet therapy and a risk of bleeding when continuing this treatment. Therefore, cardiologists should choose carefully the type of coronary stent before insertion and concerned physicians (anaesthesiologists, surgeons, cardiologists) should decide a perioperative strategy in these high-risk patients.
authors: Service d'anesthésie-réanimation, hôpital cardiovasculaire et pneumologique Louis-Pradel, hospices civils de Lyon, Lyon-Bron cedex, France. jean-jacques.lehot@chu-lyon.fr <jean-jacques.lehot@chu-lyon.fr>
authors: J-J
authors: JJ
authors: Lehot
authors: P
authors: P
authors: Staat
authors: P
authors: P
authors: Ffrench
authors: Z
authors: Z
authors: Vichova
authors: M
authors: M
authors: Cannesson
mesh_terms: D000758:Anesthesia; D003131:Combined Modality Therapy; D023921:Coronary Stenosis / Q000628:therapy*; D016503:Drug Delivery Systems; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D015607:Stents
chemical_list: D005343:Fibrinolytic Agents